Also trades as: FRX.TO (TSX) · $vol 0M
FENC Earnings
Fennec Pharmaceuticals Inc.
1W: +1.5%
1M: -3.0%
3M: +10.1%
YTD: +38.3%
1Y: +18.1%
3Y: +56.0%
5Y: +19.5%
$10.62
+0.47 (+4.63%)
Weekly Expected Move ±5.8%
$9
$9
$10
$11
$11
Credit Risk of going bust: not rated Debt: 0.0% of company value Bonds: none of note held by US funds details ▾
Not rated: no debt. Altman Z'' -3.46.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Last Earnings
2026-08-11
EPS
$0.05
▲ Beat +150.0%
Revenue
$18M
▲ Beat +10.3%
EPS Beat Streak: 2 quarters
Next Earnings
2026-11-12
EPS Estimate
$0.13
Range: $0.10 - $0.17
Revenue Estimate
$21M
4 analysts
Estimate vs Actual
Earnings Surprise History
7/19
EPS Beats
6/19
Revenue Beats
37%
EPS Beat Rate
32%
Rev Beat Rate
Wall Street Forward Estimates
Quarterly
Annual
Estimate Revisions
Recent Revisions
| Date | Period | Fiscal Date | EPS Old | EPS New | Change | Rev Old | Rev New |
|---|---|---|---|---|---|---|---|
| 2026-09-10 | annual | 2026-12-31 | $0.30 | $0.28 | ▼ 0.02 | $72,866,000 | $72,562,333 |
| 2026-09-10 | quarter | 2027-03-30 | $0.16 | $0.15 | ▼ 0.01 | $22,334,250 | $22,247,400 |
| 2026-09-10 | quarter | 2027-09-30 | $0.26 | $0.26 | — | $26,866,000 | $26,732,800 |
| 2026-09-10 | quarter | 2026-12-30 | $0.13 | $0.13 | — | $20,846,600 | $20,681,167 |
| 2026-09-10 | quarter | 2027-06-30 | $0.20 | $0.20 | — | $24,553,250 | $24,462,600 |
| 2026-09-10 | annual | 2027-12-31 | $0.96 | $0.94 | ▼ 0.02 | $103,730,600 | $103,112,333 |
| 2026-09-10 | quarter | 2027-12-30 | $0.30 | $0.30 | — | $28,784,750 | $28,587,800 |
| 2026-09-10 | quarter | 2026-09-30 | $0.10 | $0.09 | ▼ 0.01 | $19,047,200 | $18,907,333 |
| 2026-08-31 | quarter | 2028-09-30 | $0.31 | $0.31 | — | $33,777,500 | $28,700,000 |
| 2026-08-31 | quarter | 2026-12-30 | $0.13 | $0.13 | — | $20,905,500 | $20,846,600 |
| 2026-08-31 | quarter | 2026-09-30 | $0.10 | $0.10 | — | $19,206,000 | $19,047,200 |
| 2026-08-31 | quarter | 2028-03-30 | $0.16 | $0.16 | — | $29,435,500 | $24,500,000 |
| 2026-08-31 | quarter | 2027-09-30 | $0.26 | $0.26 | — | $26,732,800 | $26,866,000 |
| 2026-08-31 | quarter | 2027-06-30 | $0.20 | $0.20 | — | $24,462,600 | $24,553,250 |
| 2026-08-31 | annual | 2026-12-31 | $0.29 | $0.30 | ▲ 0.01 | $72,905,000 | $72,866,000 |
Earnings Call Transcripts
No transcript available.